Precision BioSciences (DTIL) Earnings Date & Reports

Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

DTIL is expected to report earnings to fall 70.67% to -21 cents per share on August 06

Precision BioSciences DTIL Stock Earnings Reports

Q2'26

Est.

$-0.22

Q1'26

Missed

by $0.57

Q4'25

Beat

by $1.69

Q3'25

Missed

by $1.03

Q2'25

Missed

by $1.59

The last earnings report on May 05 showed earnings per share of -75 cents, missing the estimate of -18 cents. With 82.18K shares outstanding, the current market capitalization sits at 158.68M.

View a ticker or compare two or three

Compare

DTIL

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for DTIL